SCHEMBL5773324

SCHEMBL5773324

O=C(N(CCCc1cnoc1-c1ccc(F)cc1)Cc1cccnc1)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.41
NAMPT P43490 3/20 0.39
PKM P14618 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HTR5A P47898 3/20 0.38
HTR1A P08908 1/20 0.38
DRD2 P14416 1/20 0.38
DRD4 P21917 1/20 0.38
HTR1D P28221 1/20 0.38
HTR1B P28222 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR7 P34969 1/20 0.38
ADRA1B P35368 1/20 0.38
DRD3 P35462 1/20 0.38
HTR2B P41595 1/20 0.38
KDM4E B2RXH2 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5771361 0.93 NAMPT (0.42) CYP3A4NAMPTGAAPTAFRTBXAS1
SCHEMBL5774478 0.92 HIF1A (0.42) CYP3A4NAMPTMAPTHTR5AHTR1A
SCHEMBL5771831 0.89 HDAC8 (0.34) CYP3A4NAMPTHDAC8
SCHEMBL5773874 0.84 MAPT (0.42) CYP3A4NAMPTMAPTPTAFRTBXAS1
Trifluoroacetic Acid SCHEMBL5776953 0.84 PKM (0.48) CYP3A4NAMPTPKMALDH1A1MAPT
SCHEMBL5773577 0.83 NAMPT (0.35) NAMPTDRD4HDAC4HDAC1HDAC8
SCHEMBL5770602 0.83 ALDH1A1 (0.36) NAMPTALDH1A1MAPTKDM4EHDAC1
SCHEMBL5777440 0.80 HDAC8 (0.35) CYP3A4HTR5AKDM4EHDAC4HDAC8
SCHEMBL5775533 0.79 HDAC8 (0.33) HDAC4HDAC8
SCHEMBL5771067 0.78 HDAC8 (0.35) HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR CYP3A4 39/4885NAMPT 2451/4885PKM 2534/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 CYP3A4 76/4885NAMPT 2378/4885PKM 1824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.